Eye Laser Industry - VISX and Summit BEAM Info Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eye Laser Industry - VISX and Summit BEAM Info

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AgAuUSA who wrote (55)	9/9/1996 9:38:00 PM
From: John Binford, Jr.	of 178

I was a little surprised to see both Summit and Visx weaken today in a strong market. It seems to me that Summit is worth at least $5 considering they get 44% of the per procedure fees from PPP. I believe that in a two or three years the number of procedures will be pushing up near 1 million per year. At that rate, the royalties should be enormous. I also don't think the PPP per procedure fee will be reduced for quite a while. Both Visx and Summit have put out around $50 million each and are entitled to a return on their investment for their FDA approved and patented technology. I would think that both stocks would start to rise over the next few months. For Visx, positive news in terms of another record earnings report and approval (anticipated by year end) for astigmatism should be forthcoming. For Summit, I'm not sure what good news is pending in the immediate future. Potentially this could be some good numbers on procedures performed. Or maybe management will address the bleeding of money and settle the lawsuit with Visx. Best of luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next